PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Alabama at Birmingham.\', \'Harvard Medical School and Massachusetts General Hospital, Boston.\', \'Monash University and Alfred Hospital, Melbourne, Australia.\', \'University of California, Los Angeles.\', \'AIDS Research Consortium of Atlanta, Atlanta, Georgia.\', \'Harvard Medical School and Brigham and Women\'s Hospital, Boston, Massachusetts.\', \'University of California, San Diego, La Jolla.\', \'San Francisco Department of Public Health and University of California, San Francisco.\', \'Emory University School of Medicine, Atlanta, Georgia.\', \'School of Medicine, University of North Carolina, Chapel Hill.\', \'University Hospital Cologne, Cologne, Germany.\', \'University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.\', \'University of Paris and Saint-Louis/Lariboisière Hospitals, APHP, Paris, France.\', \'International Antiviral Society-USA, San Francisco, California.\', \'University of California, San Francisco.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jama.2020.17025
?:doi
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 33052386
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all